Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Expert Review of Anti-Infective Therapy|May 9, 2017
Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging roleJordi Bozzo, Juan I JorqueraBiologicals : Journal of the International Association of Biological Standardization|February 17, 2005
Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples under long-term storageMarta José, Rodrigo Gajardo, Juan I JorqueraJournal of Alzheimer'S Disease : JAD|January 11, 2012
Therapeutic albumin binding to remove amyloid-βMontserrat Costa, Ana M Ortiz, Juan I JorqueraBiologicals : Journal of the International Association of Biological Standardization|March 31, 2010
Viral safety characteristics of Flebogamma DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulinSantiago Caballero, Sandra Nieto, Rodrigo Gajardo, et al.Biologicals : Journal of the International Association of Biological Standardization|March 8, 2003
The effect of storage at different temperatures on the stability of Hepatitis C virus RNA in plasma samplesMarta José, Sònia Curtu, Rodrigo Gajardo, et al.Stem Cell Research & Therapy|April 19, 2015
Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma poolsJosé M Díez, Ewa Bauman, Rodrigo Gajardo, et al.Journal of Alzheimer'S Disease : JAD|September 28, 2013
In vitro amyloid-β binding and inhibition of amyloid-β self-association by therapeutic albuminJulijana Milojevic, Montserrat Costa, Ana M Ortiz, et al.Biologicals : Journal of the International Association of Biological Standardization|September 25, 2010
Capacity of the manufacturing process of Flebogamma(®) DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agentJosé M Diez, Santiago Caballero, Francisco Belda, et al.Clinical and Diagnostic Laboratory Immunology|September 11, 2003
Neutralization of measles virus infectivity and antibody-dependent cell-mediated cytotoxicity activity against an Epstein-Barr virus-infected cell line by intravenous immunoglobulin G [corrected]MariCarmen Colomar, Irene Puga, Maite López, et al.Biologicals : Journal of the International Association of Biological Standardization|September 21, 2013
Flebogamma(®) DIF (intravenous immunoglobulin) purification process effectively eliminates procoagulant activitiesMarta José, Núria Marzo, Berta Pons, et al.Pageof 2